首页|头孢呋辛钠联合无创正压通气治疗COPD合并呼吸衰竭患者的疗效观察

头孢呋辛钠联合无创正压通气治疗COPD合并呼吸衰竭患者的疗效观察

扫码查看
目的:探讨头孢呋辛钠联合无创正压通气(NIPPV)治疗慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者的疗效.方法:将 100 例COPD合并呼吸衰竭患者随机分为对照组(n = 50)和观察组(n = 50),对照组单用NIPPV治疗,观察组联合头孢呋辛钠.对比 2 组动脉血气指标、肺功能指标、临床治疗有效率和不良反应发生情况.结果:治疗后,与对照组相比,观察组A-aDO2、pH、PaO2 较高,OI、PaCO2 较低;FEV1/FVC和FEV1%pred较高.观察组总有效率高于对照组(96.0%vs 72.0%),不良反应发生率低于对照组(2.0%vs 18.0%),差异均有统计学意义.结论:头孢呋辛钠联合NIPPV治疗COPD合并呼吸衰竭,可有效改进患者临床症状,提升治疗效果,减少不良反应发生.
Efficacy of cefuroxime sodium combined with non-invasive positive pressure ventilation in the treatment of patients with COPD combined with respiratory failure
Objective:To investigate the efficacy of cefuroxime sodium combined with non-invasive positive pressure ventilation(NIPPV)in the treatment of patients with chronic obstructive pulmonary disease(COPD)complicated with respiratory failure.Methods:One hundred cases of the patients were randomly divided into a control group(n=50)and an observation group(n=50).The control group was treated with NIPPV alone,and the observation group was treated with NIPPV combined with cefuroxime sodium.The arterial blood gas indexes,pulmonary function indexes,clinical treatment efficiency and the incidence of adverse reactions were compared between the two groups.Results:After treatment,compared with the control group,the observation group had higher A-aDO2,pH,PaO2 values,lower OI,PaCO2 values,higher FEV1/FVC and FEV1%pred.The total effective rate was higher(96.0%vs 72.0%)and the incidence of adverse reactions was lower(2.0%vs 18.0%)in the observation group than the control group.Conclusion:The combination therapy can effectively improve the clinical symptoms of the patients and their therapeutic effect and reduce the occurrence of adverse reactions.

chronic obstructive pulmonary diseaserespiratory failurecefuroxime sodiumnon-invasive positive pressure ventilation

王广林、孙军杰、刘加彬

展开 >

郑州市第三人民医院急诊与重症医学科 郑州 450000

慢性阻塞性肺疾病 呼吸衰竭 头孢呋辛钠 无创正压通气

2024

上海医药
上海医药行业协会

上海医药

影响因子:0.781
ISSN:1006-1533
年,卷(期):2024.45(7)
  • 11